Drugs / ACT-453859
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02381496 | Dec 2011 → Apr 2012 | — | Idorsia Pharmaceuticals Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACT-453859 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02381496 ↗ |
| Route | Oral | “single oral dose of ACT-453859” NCT02381496 ↗ |